News Only difference between LSD and synthetic psilocybin experience is duration, researchers say But there are some physiological differences between the two Natalia Buendia CalvilloMarch 2, 2022
News Psilocybin therapy for major depression can relieve symptoms for a year: study The long-term benefits contrast with the more temporary effects of conventional antidepressants Natalia Buendia CalvilloFebruary 18, 2022
Canada Canadian health professionals are limited to clinical trials to access psilocybin. Experts say that’s unethical Health Canada's guidance on how to access illicit substances for medical purposes has been a moving target over the past year Natalia Buendia CalvilloFebruary 16, 2022
Canada Canadian advocates denounce ‘flawed’ system for legal psilocybin access It appeared Health Canada was increasing access to the substance, but recent events suggest otherwise Natalia Buendia CalvilloFebruary 3, 2022
Business Numinus uplists to OTCQX Best Market Stock will start trading at market open Thursday under the symbol NUMIF Natalia Buendia CalvilloJanuary 26, 2022
Canada What amendments to Canada’s restricted drug program mean for patients and practitioners The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say Natalia Buendia CalvilloJanuary 11, 2022
Canada Health Canada to increase legal access to psychedelics for therapy Psychedelics firm Numinus says amendments made to the country's Special Access Programme come into effect in January Natalia Buendia CalvilloDecember 28, 2021
Business Numinus ends fiscal year with revenue up 72% to $1.5M, losses of $19M The psychedelics firm has been aggressively expanding lab space while pushing ahead with clinical trials Natalia Buendia CalvilloDecember 10, 2021
Business Field Trip Health opens clinic in Vancouver: Q&A with founder Ronan Levy The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services Nick LabaDecember 8, 2021
Medical and Pharmaceutical Common antidepressant escitalopram and psilocybin can be taken together safely: study Research funded by MindMed suggests some antidepressants can reduce the unwanted side effects of psychedelics Natalia Buendia CalvilloDecember 1, 2021